XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net product sales $ 141,517 $ 103,501 $ 378,589 $ 284,274
Cost of goods sold 13,279 9,946 38,107 26,002
Gross profit 128,238 93,555 340,482 258,272
Operating expenses:        
Research and development 26,160 40,704 79,172 117,352
Selling, general, and administrative 75,106 65,651 236,711 205,031
Changes in fair value of contingent consideration payable 0 1,995 0 2,583
Restructuring charges 3,143 0 9,188 0
Loss on impairment of assets 0 0 0 1,134
Depreciation and amortization 2,170 2,228 6,506 5,691
Total operating expenses 106,579 110,578 331,577 331,791
Income (loss) from operations 21,659 (17,023) 8,905 (73,519)
Other expense:        
Interest income 1,081 1,471 3,991 5,407
Interest expense (12,692) (12,986) (37,640) (37,322)
Other (expense) income (3,263) 3,833 (11,946) (13,007)
Income (loss) before income tax 6,785 (24,705) (36,690) (118,441)
Income tax (expense) benefit (13,514) 3,128 (34,155) 700
Net loss attributable to common stockholders $ (6,729) $ (21,577) $ (70,845) $ (117,741)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.02) $ (0.07) $ (0.23) $ (0.40)
Net loss attributable to common stockholders per common share — diluted (in dollars per share) $ (0.02) $ (0.07) $ (0.23) $ (0.40)
Weighted average common shares outstanding - basic (in shares) 304,690,596 295,759,435 303,792,479 293,314,167
Weighted average common shares outstanding - diluted (in shares) 304,690,596 295,759,435 303,792,479 293,314,167